For more than two decades ThermoGenesis Holdings, Inc. has developed and commercialized novel cell processing systems and devices providing global researchers, biomanufacturing organizations and clinicians with highly efficient cell processing devices which have enabled their delivery of better outcomes in various applications in the cell and gene therapy field. Structured around ensuring the future benefit of cell and gene therapy through reduction of drug manufacturing cost and increased patient accessibility, ThermoGenesis collaborates with leading academic institutions and industry partners to develop the best products for their specific processes.
